NCT06430385 · Interventional trial
ATTUNE: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intrathecally-Administered ION440 in Participants With Methyl CpG Binding Protein 2 (MECP2) Duplication Syndrome (MDS)
Overall registry status Recruiting
Phase 1 · Phase 2
Conditions Methyl CpG Binding Protein 2 (MECP2) Duplication Syndrome
Delaware Valley sites
- Children's Hospital of Philadelphia · Philadelphia, PA · Philadelphia County · Recruiting
First posted
Registry updated
Added to the directory